Showing 3001-3010 of 3223 results for "".
- 2019 American Academy of Optometry Resident Travel Fellowship Recipients Announcedhttps://modernod.com/news/2019-american-academy-of-optometry-resident-travel-fellowship-recipients-announced/2476868/The American Academy of Optometry named the recipients of the 2019 Resident Travel Fellowship Awards. These travel fellowships will allow residents to attend Academy 2019 Orlando and 3rd World Congress of Optometry, October 23-27, 2019. Allergan Resident
- CorNeat Vision Completes Preclinical Phase For Synthetic Cornea and Scleral Patchhttps://modernod.com/news/corneat-vision-completes-preclinical-phase-for-synthetic-cornea-and-scleral-patch/2479538/CorNeat Vision announced it has completed the preclinical stage of its cornea implant (CorNeat KPro/Keratoprosthesis) and the first synthetic, non-degradable scleral patch (CorNeat EverPatch). The company’s solutions, which also include a glaucoma drainage device, the CorNeat eShunt, will b
- Cigna Rolls Out New Plan to Fully Cover Multi-Million Dollar Gene Therapieshttps://modernod.com/news/cigna-rolls-out-new-plan-to-fully-cover-multi-million-dollar-gene-therapies/2479539/Health insurer Cigna Corp has introduced a plan to fully cover costs for expensive gene therapies, eliminating any out-of-pocket payments for customers, according to a Reuters report. Gene therapies, which in general aim to treat di
- iSTAR Medical Announces EUR 40 Million Series C Financinghttps://modernod.com/news/istar-medical-announces-eur-40-million-series-c-financing/2479542/iSTAR Medical announced the completion of a €40m Series C financing to support the development of iSTAR Medical’s MINIject device along the path to commercialization in Europe and the United States. MINIject, an ab-interno MIGS device, provides a powerful and reliable sol
- OD-OS to Showcase Navilas Navigated Retinal Laser Therapy at EURETINAhttps://modernod.com/news/od-os-to-showcase-navilas-navigated-retinal-laser-therapy-at-euretina/2476852/OD-OS will share clinical experiences with the Navilas 577s digital treatment platform this week at the EURETINA Congress in Paris. Navigated retinal laser therapy with the Navilas 577s allows for panretinal photocoagulation with uniform spot distribution, which is faster and less painful for pat
- Oculus Release Myopia Master for Myopia Managementhttps://modernod.com/news/oculus-release-myopia-master-for-myopia-management/2476839/Oculus has introduced the Myopia Master, a device designed to combine all the important measurement methods of myopia management: axial length, refraction values, and the central corneal radii. The Oculus Myopia Master creates a myopia report for each patient, giving due consideration to s
- Lenstec Completes FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-fda-trial-for-sbl-3-iol/2476837/Lenstec announced that it has completed its FDA trial for the SBL-3 IOL (Segmented Bifocal Lens), an asymmetric multifocal refractive IOL designed to provide patients with superior near, intermediate, and distance vision. It also offers improved contrast sensitivity and minimizes halos and glare
- Japan Conducts World’s First Transplant With iPS Cells for Corneal Diseasehttps://modernod.com/news/japan-conducts-worlds-1st-transplant-with-ips-cells-for-corneal-disease/2476836/A research team from Japan’s Osaka University said Thursday that it has conducted the world’s first transplant for corneal disease using induced pluripotent stem (iPS) cells. The team conducted the surgery in July, allowing iPS corneal tissues to replace the current queuing for cornea
- Topcon Announces the Release of Harmony Into the EMEA Regionhttps://modernod.com/news/topcon-announces-the-release-of-harmony-into-the-emea-region/2476835/Topcon has announced the release and clearance of the Topcon Harmony, a class II medical diagnostic software, into the EMEA market. Topcon Harmony is a responsive browser-based software application for on-site or cloud-hosted environments that allows practitioners to connect all of their diagnost
- Orbis Celebrates New Data Showing a 91% Reduction in Populations at Risk of Blinding Trachoma in Endemic Areashttps://modernod.com/news/orbis-celebrates-new-data-showing-a-91-reduction-in-populations-at-risk-of-blinding-trachoma-in-endemic-areas/2479544/The World Health Organization (WHO) announced new data that revealed the number of people at risk for trachoma had fallen from 1.5 billion in 2002 to 142 million in 2019—a 91% reduction, according to Orbis International. The report was released at the annual meeting of the WHO Alliance fo